Article
Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering
2019-02-15
Abstract excerpt
Hybridoma technology is instrumental for the development of novel antibody therapeutics and diagnostics. Recent preclinical and clinical studies highlight the importance of antibody isotype for therapeutic efficacy. However, since the sequence encoding the constant domains is fixed, tuning antibody function in hybridomas has been restricted. Here, we demonstrate a versatile CRISPR/HDR platform to rapidly engineer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a17dab2c-0f9d-5d32-916f-393c7153539f
- DOI
- 10.1101/551382
